WOODCLIFF LAKE, N.J. , Sept. 29, 2016 /PRNewswire/ --Eisai Inc. announced today the presentation of seven abstracts featuring data on its cancer... ...http://in.advfn.com/news_New-Halaven-eribulin-and-Lenvima-lenvatinib-Data_72553275.html
Peripneumonia, and pleuritic affections, re to be thus observed: If the fever be acute, and if there be pains on either side, or in both, and if... ...http://www.medindia.net/patients/patientinfo/pneumonia.htm
Amgen Announces Top-Line Results From Phase 3 KYPROLIS® (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients Tuesday,... ...https://www.pharmafocusasia.com/pressreleases/amgen-announces-top-line-results-from-phase-3-kyprolis-carfilzomib-clarion-study-in-newly-diagnosed-multiple-myeloma-patients
NORTH CHICAGO, Ill. , Sept. 26, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that it submitted a... ...http://in.advfn.com/news_AbbVie-Announces-Submission-of-a-Supplemental-New_72520188.html
GSK today announced that it has filed regulatory submissions in the US and Europe for Benlysta® (belimumab) for approval as a subcutaneous... ...http://www.pressreleasepoint.com/gsk-announces-regulatory-submissions-subcutaneous-formulation-benlysta-belimumab-patients-systemic-l
Gamboge tree is moreover declared via...